CME Names Lynne Fitzpatrick CEO for 2027 as Terry Duffy Shifts to Executive Chairman
Updated
Updated · Markets Media · Jun 17
CME Names Lynne Fitzpatrick CEO for 2027 as Terry Duffy Shifts to Executive Chairman
3 articles · Updated · Markets Media · Jun 17
Summary
March 1, 2027 is the handover date for CME Group, when President and CFO Lynne Fitzpatrick will become CEO and join the board while Terry Duffy moves to executive chairman.
25 years of Duffy leadership reshaped CME from a floor-based exchange into an electronic derivatives giant, with average daily volume reaching 28.1 million contracts last year.
More than $95 billion in market value and an 8,000%-plus rise since CME went public in 2002 frame the scale of the business Duffy built through the CBOT merger, NYMEX acquisition and later deals.
Fitzpatrick, CFO since 2023 and president since 2024, joined CME in 2006 and is being elevated after holding treasury, corporate development and deputy CFO roles.